Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the ...
Zacks Investment Research on MSN
CDE vs. HL: Which gold miner offers better value today?
Coeur Mining, Inc. CDE and Hecla Mining Company HL have been in focus as the broader gold and silver markets show strong ...
After yet another disappointing year, the Jets head back to the draft board early. With new GM Darren Moguey, they should ...
Atebimetinib is an investigational oral deep cyclic inhibitor that targets MEK in the MAPK pathway, which is activated in many solid tumors including pancreatic cancer. Its mechanism of action is ...
A groundbreaking study reveals that sacituzumab govitecan and pembrolizumab significantly enhance survival in untreated metastatic triple-negative breast cancer patients.
College football's 2026 transfer portal cycle has been unlike any other, compressed into a 15-day window that kicked off the ...
Although the deadline for declaring for the 2026 NFL Draft is not until January 23, Dante Moore’s decision to return to ...
Adding chemotherapy and bevacizumab to immunotherapy improves tumor control in a high-risk CRC subset, but this benefit comes ...
Wisconsin utilized a smaller lineup with four guards for about nine minutes and outscored Michigan during that time. The smaller lineup combinations were partly a necessity while Austin Rapp was out, ...
VMT01 is a MC1R-targeted RPT that can be radiolabeled with either (203) Pb for patient selection and dosimetry assessments, or (212) Pb for alpha particle therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results